20.09.2024, 13:03

SPH Sales revenues for August 2024

Sofia, Bulgaria, September 20, 2024 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for August 2024 the Company recorded a decrease in sales of 3% compared to the same month of the previous year, incl. 30% increase in domestic sales and 16% decrease in export sales.
For the period from the beginning of 2024, the Company recorded a decrease in sales of 7%, incl. 8% increase of domestic sales and 15% decrease in export sales.

Załączniki

Pobierz załącznik 1

Inne komunikaty

Data	Tytuł	Kurs	Zmiana
2024-11-20	SPH Sales revenues for October 2024	13,00	+0,38
2024-10-30	SPH Individual financial report according to IFRS as at 30 September 2024	12,25	+13,88
2024-10-30	SPH Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda district, 16 Iliensko shose Str. by exercising warrants from the issue with ISIN BG9200001212	12,25	+13,88
2024-10-25	SPH Minutes of the Extraordinary General Meeting of Shareholders of Sopharma AD, held on October 25, 2024 from 11:00 a.m. (UTC 8:00)	12,25	0,00
2024-10-25	SPH Notification for dividend payment	12,25	0,00
2024-10-21	SPH Sales revenues for September 2024	13,30	0,00
2024-10-14	SPH Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda district, 16 Iliensko shose Str. by exercising warrants from the issue with ISIN BG9200001212	14,00	0,00
2024-10-04	SPH Notification for initiation of acquisition transaction	12,80	0,00
2024-10-01	SPH Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	14,00	0,00
2024-09-30	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	14,00	0,00

Wszystke komunikaty